← Database
M&A

DCC HEALTHCARE

Acquired by

INVESTCorporate

UNITED KINGDOM Life Sciences / Pharma & Biotech / CDMO EV 1b GBP - 100b GBP 09/2025

Target

DCC HEALTHCARE

Acquirer

INVESTCorporate

Context

InvestIndustrial finalized the acquisition of DCC Healthcare Limited from the London-listed group DCC plc. This transaction is a strategic corporate carve-out designed to simplify DCC plc's operations, allowing the group to focus resources on its largest and most profitable Energy division. The proceeds from the sale are earmarked for distribution to DCC shareholders. The deal received regulatory approval from the European Commission.

DCC HEALTHCARE, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (13.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

DCC Healthcare is a leading healthcare business providing products and services to health and beauty brand owners and healthcare providers. It operates as a CDMO (Contract Development and Manufacturing Organization) and distributes medical devices and pharma products.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (GBP)

Year
Rev
EBITDA
EBIT
2024
LOGIN
LOGIN
LOGIN
2023
LOGIN
LOGIN
LOGIN

Other operations with DCC HEALTHCARE

REFERENCES

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: investcorporate